Search Tag: remdesivir
2021 16 Feb
Mortality trials of four antiviral drugs - remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a were recommended by the World Health Organization (WHO) to evaluate their effect in patients hospitalised with COVID-19. In March 2020, the WHO began a large international trial that included hospital inpatients to evaluate the effects...Read more
2020 14 Nov
There have been over 47 million cases of COVID-19 globally and 1.2 million deaths. According to Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), the treatment of patients with early COVID-19 infection requires urgent focus. Treating these patients early in the course of infection could help speed up their...Read more
2020 29 Jun
One solution to the problem of scarce medications allocation, which has been exacerbated by the COVID-19 pandemic, can be the implementation of a centralised lottery system, an article in JAMA argues. You might also like: EMA Fast-Tracking Procedures for COVID-19 Medicines The authors (White and Angus 2020) take as an example...Read more
2020 27 May
The UK health ministry has announced that the antiviral drug remdesivir would be made available to selected COVID-19 patients while the World Health Organization (WHO) is putting the hydroxychloroquine/chloroquine arm within the COVID-19 Solidarity Trial on hold. You may also like : From Hydroxychloroquine and Remdesivir to Plasma Administration...Read more
2020 19 May
Clinicians are faced with a serious disease with no effective therapy. Several options are being considered to treat COVID-19, but how promising are these drugs? A number of colleagues and friends from outside the hospital have asked me whether they should take hydroxychloroquine for their COVID-19. A friend asked me whether he should...Read more
2020 06 May
The search for a drug to treat patients with coronavirus disease (COVID-19) has created an interest in a relatively new antiviral drug called remdesivir. Although the majority of patients who acquire coronavirus only develop a self-limited mild illness, around 10-20% of patients develop severe pneumonia and respiratory distress that requires ICU care,...Read more